I-RECOVER: LONG COVID TREATMENT
An Approach to Treating Long COVID
Up to 80% of patients experience prolonged illness after COVID-19, characterized by prolonged malaise, headaches, generalized fatigue, sleep difficulties, hair loss, smell disorder, decreased appetite, painful joints, dyspnea, chest pain and cognitive dysfunction. Long COVID may persist for months after acute infection, and it is likely that patients who did not receive adequate treatment during the symptomatic phase are much more likely to develop long COVID. Treatment should be individualized to clinical signs and symptoms.
About this ProtocolThe information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature.
It is provided as guidance to healthcare providers worldwide on the early treatment of COVID-19. Patients should always consult with their provider before starting any medical treatment.
ABOUT EARLY TREATMENT LLC
Our products are created with only the most premium components. Our medicines are vetted and have decades-long, stellar safety records. Our treatments are developed and compounded for you, to ensure maximum efficacy.
Our goal is to help humanity prepare for the worst, so we can live our best lives without fear.
Do you find this information useful?
Please show your appreciation.
One Time Tip
It's Likely You Have Been
Without Your Knowledge or Consent.
Correct Your Political Status.
Protect Yourself from Government Overreach.
Restore Lawful Government.
Body and Health Support